JESSICA GALLAGHER: Open Payments
NPI 1730582313 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 71 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $508 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $166 |
| ABBVIE INC. | 9 | $165 |
| Novo Nordisk Inc | 9 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $133 |
| Amgen Inc. | 7 | $124 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| PFIZER INC. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $42 |
Products named: LEQVIO, ELIQUIS, OTEZLA, VRAYLAR, UBRELVY, MOUNJARO, JARDIANCE, Wegovy.
Industry payments across MO — which companies pay providers there.
